Results 231 to 240 of about 5,416,068 (411)
Molecular Oncology, EarlyView.Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma +9 more
wiley +1 more source
Lives of a Cell: 40 Years Later, A Third Interpretation
Emerging Infectious Diseases, 2015 Virginia M. Dato
doaj +1 more source
XVIII.—Notes from the Gatty Marine Laboratory, St. Andrews.—No. XXXV [PDF]
, 1913 M'Intosh
openalex +1 more source
Landscape of BRAF transcript variants in human cancer
Molecular Oncology, EarlyView.We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda +5 more
wiley +1 more source
XIV.—Communications from the Laboratory of the London Institution. No. I.—On the formation of sulpho-acids [PDF]
, 1871 HENRY E. ARMSTRONG
openalex +1 more source
Climate change and medical laboratory operations: Impacts, challenges, and adaptation strategies: A narrative review. [PDF]
Medicine (Baltimore)Obeagu EI, Bolo B.
europepmc +1 more source
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren +16 more
wiley +1 more source